Abstract: Neuroinvasive and neurovirulent strain of the West Nile virus, named IS-98-ST1, nucleic acid molecules derived from its genome, proteins and peptides encoded by said nucleic acid molecules, and uses thereof.

Abstract: Oligonucleotides having a nucleotide sequence complementary to nucleotide numbers such as 2571-2607, 2578-2592, 2571-2592, 2573-2592, 2578-2596, 2578-2601 or 2575-2592 of the dystrophin cDNA (Gene Bank accession No. NM_004006.1) and therapeutic agents for muscular dystrophy comprising such oligonucleotides.

Abstract: The combined use of 1,2-dilinoleoyl-sn-glycero-3-phosphocholine and 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine affords a superior anti-depressive action, an improving effect on the cognitive function associated with depression, an improving effect on the stress-induced suppression of Akt activation, and a suppressive action on the stress-induced GSK-3? activation. Therefore, the present invention can provide an antidepressant combination drug, an agent for improving cognitive function associated with depression, an agent for improving stress-induced suppression of Akt activation and an agent for suppressing stress-induced GSK-3? activation.

Abstract: Disclosed herein are a microelectromechanical systems (MEMS) microphone with a dual-back plate, and a method of manufacturing the same. The MEMS microphone according to an exemplary embodiment of the present invention includes: a substrate having a first back plate formed at a central portion thereof; a membrane plate disposed on first support parts formed at both sides on the substrate and vibrated depending on external sound pressure; and a second back plate disposed on second support parts formed at both sides of the membrane plate.

Abstract: The invention provides a first-order phase-transition La(Fe,Si)13-based magnetocaloric material showing small hysteresis loss, and preparation and use thereof. The material has a NaZn13-type structure, is composed of granules with a particle size in the range of 15˜200 ?m and not less than 15 ?m, and is represented by chemical formula La1-xRx(Fe1-p-qCopMnq)13-ySiyA?. The method for preparing the material comprises steps of preparing the material La1-xRx(Fe1-p-qCopMnq)13-ySiyA? by smelting and annealing; and then crushing the material into powder with a particle size in the range of 15˜200 ?m. Without changing the components, a La(Fe,Si)13-based magnetocaloric material showing small hysteresis loss and strong magnetocaloric effect can be obtained by adjusting the particle size within the range of 15˜200 ?m. Utilization of this type of materials in the practical magnetic refrigeration application is of great significance.

Abstract: Heat storage apparatus comprising at least one thermal store (300) comprising a chamber (301) having a gas inlet (306), a gas outlet (307), and a gas-permeable thermal storage media (303) disposed therebetween, the apparatus being configured such that, during operation, the flow path of a gas flowing through the chamber (301) from inlet (306) to outlet (307) for transfer of thermal energy to or from the storage media (303) can be selectively altered in response to the progress of the thermal transfer, thereby enabling the flow path to bypass inactive upstream or downstream regions of the storage media where thermal transfer is complete or minimal, so as to minimize the pressure drop across the storage media. A baffle system (305) in a main flow passageway (312) may be used to control the gas flow path.

Abstract: The present invention relates to a pharmaceutical composition for preventing or treating diabetes or dementia, comprising centipede grass (Eremochloa ophiuroides) extracts as an active ingredient. It has been identified from animal tests that the centipede grass extracts, fractions thereof, and active fractions separated from the said fractions effectively regulate blood glucose levels, and inhibit the activity of amyloid-?(A?) which is involved in the formation of amyloid plaques that might cause dementia. Thus, the extracts, the fractions thereof, and the active fractions separated from the said fractions can be effectively used in a composition for preventing and treating diabetes or dementia, in a functional food for preventing or improving diabetes or dementia, and in a pharmaceutical composition or health food for blood glucose regulation.

Abstract: An isolated peptide for inhibiting melanogenesis in a mammal subject is provided. The isolated peptide consisting of an amino acid sequence of SSASTTED (SEQ ID NO: 1). Also provided are methods and compositions for inhibiting melanogenesis in a mammal subject.

Abstract: A power converter circuit rectifies a line voltage and applies the rectified voltage to a stack of capacitors. Voltages on the capacitors are coupled to a plurality of regulating converters to be converted to regulated output signals. The regulated output signals are combined and converted to a desired DC output voltage of the power converter. Input currents of the regulating converters are modulated in a manner that enhances the power factor of the power converter.

Abstract: A device for measuring point diffraction interferometric wavefront aberration having an optical source, an optical splitter, a first light intensity and polarization regulator, a phase shifter, a second light intensity and polarization regulator, an ideal wavefront generator, an object precision adjusting stage, a measured optical system, an image wavefront detection unit, an image precision adjusting stage, and a data processing unit. A method for detecting wavefront aberration of the optical system by using the device is also disclosed.

Abstract: A method of device-to-device (D2D) communication and apparatus thereof are provided. A communication method performed in a second device according to an embodiment of the present invention comprising: receiving first configuration information for receiving reference signal and second configuration information for transmitting channel state information from a base station; receiving the reference signal based on the first configuration information from the first device; generating the channel state information on a communication link between the first device and the second device based on the reference signal; and transmitting the channel state information based on the second configuration information to the base station. Accordingly, the D2D communication may be performed effectively.

Abstract: An aqueous liquid medium for analyzing, purifying or separating species in an element having walls or for treating the walls of an element. The medium includes at least a polymer consisting of several polymeric segments. The polymer is of the irregular block-copolymer or irregular comb-like polymer type and has on the average at least three junction points between polymeric segments of different chemical or topological nature. The medium may be used in methods for analyzing, purifying or separating species and methods for treating an element to be contacted with a fluid and/or species contained in the fluid during preservation, transport, analysis, purification or separation of the fluid.

Abstract: The present invention relates to a full-Si molecular sieve, wherein the full-Si molecular sieve has a Q4/Q3 of (10-90):1 wherein Q4 is the peak strength at the chemical shift of ?112±2 ppm in the 29Si NMR spectrum of the full-Si molecular sieve, expressed as the peak height relative to the base line; and Q3 is the peak strength at the chemical shift of ?103±2 ppm in the 29Si NMR spectrum of the full-Si molecular sieve, expressed as the peak height relative to the base line.

Abstract: The present invention relates to a real time dynamic physics simulation device of flexible DC transmission system. The device includes simulated converter transformer, simulated AC field, simulated DC field, simulated converter reactor, simulated converter, and measurement and control cabinet chassis; the simulated AC field includes the vacuum switch I, the contactor I, resistors and the vacuum switch II connected orderly; the simulated DC field includes successively connected the vacuum switch contactor III and II; the simulated AC field is connected with said measurement and control cabinet chassis; Said converter transformer is set between said resistors and said vacuum switch II; Said simulated converter reactors and said simulated converter connected are set between the vacuum switch II and the vacuum switch III.

Abstract: The present invention relates to an n-heterocyclic carbene (NHC) type palladium catalyst and its preparation method as well as applications. Its preparation process is as below: select glyoxal as the raw material to synthesize glyoxaldiimine in the presence of Lewis acid or Bronsted acid, and then react with paraformaldehyde to get the NHC type ligand. Use palladium(II) to react with the compound containing carbon-nitrogen double bonds to get palladium(II) cyclic dimer; make the palladium cyclic dimer and the NHC type ligand coordinated to get the NHC type palladium catalyst. The palladium catalyst with a brand new structure according to the present invention, boasts high activity and multi-purpose.

Abstract: Provided is a vessel monitoring method of a vessel monitoring system, which includes receiving first vessel information from an automatic identification system message output from a vessel, receiving second vessel information on the vessel from a port management information system, selecting a vessel tracking parameter on a basis of the first vessel information and the second vessel information, and tracking the vessel by using a tacking algorithm corresponding to the vessel tracking parameter.

Abstract: Oligonucleotides having a nucleotide sequence complementary to nucleotide numbers such as 2571-2607, 2578-2592, 2571-2592, 2573-2592, 2578-2596, 2578-2601 or 2575-2592 of the dystrophin cDNA (Gene Bank accession No. NM_004006.1) and therapeutic agents for muscular dystrophy comprising such oligonucleotides.

Abstract: A DNA vaccine suitable for eliciting an immune response against cancer cells comprises a DNA construct operably encoding a cancer-associated Inhibitor of Apoptosis-family protein and an immunoactive gene product, such as a cytokine or a ligand for a natural killer cell surface receptor, in a pharmaceutically acceptable carrier. A preferred cytokine is CCL21. Preferred ligands for a natural killer cell surface receptor include human MICA, human MICB, human ULBP1, human ULBP2, and human ULBP3. The cancer-associated Inhibitor of Apoptosis (IAP)-family protein is preferably a survivin protein or livin protein. Method of inhibiting tumor growth by administering the vaccine of the invention to a mammal is also described.

Abstract: A recommendation method includes providing an ontology database, in which the ontology database includes a plurality of entities, and the entities are arranged in an ontology hierarchy structure with N hierarchy levels; storing a plurality of jth level user data respectively corresponding to a plurality of users; generating a plurality of kth level user data according to the jth level user data respectively; clustering the kth level user data; and recommending the entities in the ontology database to the users according to a clustering result.

Abstract: Provided are a method and system for providing a sleep state in a device accessible to a wired or wireless network. Provided are a method and a system, which dynamically determine the optimal parameter in a sleep state depending on a network characteristic in providing the sleep state to a network-accessible terminal, and thus reduce the period of an active state of the network-accessible terminal, thereby considerably decreasing power consumption. Provided are a method and a system, which do not unnecessarily use a clock in an active state by selecting the optimal clock according to a purpose of transiting from the sleep state to the active state, and thus reduce the period of the active state of the network-accessible terminal, thereby considerably decreasing power consumption.